FDA Issues New Recall Alert For ResMed CPAP Devices: Here's …
网页2024年6月3日 · On Jan. 12, the U.S. Food and Drug Administration classified the recall of some specific ResMed respiratory masks as Class 1, the most serious recall classification. “Use of these devices may cause serious injuries or death,” the FDA decided , typical of Class 1 classifications ( 1 ).
Why ResMed's Rally Is Just Getting Started - Seeking Alpha
网页5 天之前 · The good news for ResMed is that GLP-1 drugs are no risk. Even better, ResMed's products improve patient outcomes! According to the company, which cites a SURMOUNT-OSA study, patients with GLP-1 ...
ResMed Adopts New Operating Model to Accelerate Long-term …
网页SAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
ResMed Inc. (RMD) Latest Stock News & Headlines - Yahoo …
网页Get the latest ResMed Inc. (RMD) stock news and headlines to help you in your trading and investing decisions.
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid …
网页2024年4月17日 · In a report released today, Lyanne Harrison from Bank of America Securities reiterated a Buy rating on Resmed (RMD – Research Report), with a price target of $220.00.
Newsroom | Resmed Inc
网页2024年8月1日 · At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases.
Why ResMed Stock Is Soaring Today - Yahoo Finance
网页2024年4月26日 · Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal...
ResMed Inc. Announces Results for the Second Quarter ... - ResMed …
网页2023年12月31日 · SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2023. Second Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 12% to $1.2 billion; up 11% on a constant currency basis.
ResMed (NYSE:RMD) stock performs better than its underlying …
网页2024年9月12日 · One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Over half a decade, ResMed managed to ...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal …
网页SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2024. Fourth Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 9% to $1.2 billion; up 10% on a constant currency basis.